IBDEI0YR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16325,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,16325,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,16326,0)
 ;;=C64.2^^64^739^16
 ;;^UTILITY(U,$J,358.3,16326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16326,1,3,0)
 ;;=3^Malig Neop Kidney,Left
 ;;^UTILITY(U,$J,358.3,16326,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,16326,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,16327,0)
 ;;=C71.9^^64^739^8
 ;;^UTILITY(U,$J,358.3,16327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16327,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,16327,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,16327,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,16328,0)
 ;;=C16.9^^64^739^23
 ;;^UTILITY(U,$J,358.3,16328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16328,1,3,0)
 ;;=3^Malig Neop Stomach,Unspec
 ;;^UTILITY(U,$J,358.3,16328,1,4,0)
 ;;=4^C16.9
 ;;^UTILITY(U,$J,358.3,16328,2)
 ;;=^5000923
 ;;^UTILITY(U,$J,358.3,16329,0)
 ;;=C20.^^64^739^22
 ;;^UTILITY(U,$J,358.3,16329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16329,1,3,0)
 ;;=3^Malig Neop Rectum
 ;;^UTILITY(U,$J,358.3,16329,1,4,0)
 ;;=4^C20.
 ;;^UTILITY(U,$J,358.3,16329,2)
 ;;=^267090
 ;;^UTILITY(U,$J,358.3,16330,0)
 ;;=C43.9^^64^739^5
 ;;^UTILITY(U,$J,358.3,16330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16330,1,3,0)
 ;;=3^Malig Melanoma Skin,Unspec
 ;;^UTILITY(U,$J,358.3,16330,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,16330,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,16331,0)
 ;;=C22.9^^64^739^20
 ;;^UTILITY(U,$J,358.3,16331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16331,1,3,0)
 ;;=3^Malig Neop Liver,Unspec as Prim/Second
 ;;^UTILITY(U,$J,358.3,16331,1,4,0)
 ;;=4^C22.9
 ;;^UTILITY(U,$J,358.3,16331,2)
 ;;=^267096
 ;;^UTILITY(U,$J,358.3,16332,0)
 ;;=C32.9^^64^739^18
 ;;^UTILITY(U,$J,358.3,16332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16332,1,3,0)
 ;;=3^Malig Neop Larynx,Unspec
 ;;^UTILITY(U,$J,358.3,16332,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,16332,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,16333,0)
 ;;=C50.911^^64^739^10
 ;;^UTILITY(U,$J,358.3,16333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16333,1,3,0)
 ;;=3^Malig Neop Breast,Right,Female
 ;;^UTILITY(U,$J,358.3,16333,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,16333,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,16334,0)
 ;;=C50.912^^64^739^9
 ;;^UTILITY(U,$J,358.3,16334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16334,1,3,0)
 ;;=3^Malig Neop Breast,Left,Female
 ;;^UTILITY(U,$J,358.3,16334,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,16334,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,16335,0)
 ;;=C24.9^^64^739^6
 ;;^UTILITY(U,$J,358.3,16335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16335,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,16335,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,16335,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,16336,0)
 ;;=C90.00^^64^739^24
 ;;^UTILITY(U,$J,358.3,16336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16336,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,16336,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,16336,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,16337,0)
 ;;=C85.89^^64^739^29
 ;;^UTILITY(U,$J,358.3,16337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16337,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma NEC,Extranodal & Solid Organ
 ;;^UTILITY(U,$J,358.3,16337,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,16337,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,16338,0)
 ;;=C79.51^^64^739^32
 ;;^UTILITY(U,$J,358.3,16338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16338,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,16338,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,16338,2)
 ;;=^5001350
